Literature DB >> 7722283

Regulated expression of Ly-6A.2 is important for T cell development.

A Bamezai1, D Palliser, A Berezovskaya, J McGrew, K Higgins, E Lacy, K L Rock.   

Abstract

Ly-6A.2 is a surface protein on T cells that may play a role in lymphocyte activation. The regulation of Ly-6A.2 expression during T cell lymphopoiesis has been intriguing. It is one of the earliest markers expressed on pluripotent hemopoietic stem cells and is present on both primitive and mature T cells, but its expression is extinguished in the thymus during key developmental stages. To determine whether Ly-6A.2 is active on developing T cells, as well as the significance of its developmental regulation, Ly-6A.2 was expressed throughout T cell development under control of the T cell-specific human CD2 enhancer in transgenic mice. The constitutive overexpression of Ly-6A.2 in vivo led to a marked impairment in the generation of thymocytes. Development was arrested at the time in thymic development when Ly-6A.2 expression is normally turned off. These results indicate that the regulated expression of Ly-6A.2 in thymocytes may be important for normal development. Moreover, these findings demonstrate that Ly-6A.2 is active in the thymic microenvironment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722283

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Treatment with anti-LFA-1 alpha monoclonal antibody selectively interferes with the maturation of CD4- 8+ thymocytes.

Authors:  C Revilla; A L González; C Conde; M López-Hoyos; J Merino
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

2.  Sca-1 influences the innate immune response during skeletal muscle regeneration.

Authors:  Kimberly K Long; Grace K Pavlath; Monty Montano
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-01       Impact factor: 4.249

3.  Sca-1 is negatively regulated by TGF-beta1 in myogenic cells.

Authors:  Kimberly K Long; Monty Montano; Grace K Pavlath
Journal:  FASEB J       Date:  2010-12-14       Impact factor: 5.191

4.  Sca-1 expression is required for efficient remodeling of the extracellular matrix during skeletal muscle regeneration.

Authors:  Kimberly A Kafadar; Lin Yi; Yusra Ahmad; Leslie So; Fabio Rossi; Grace K Pavlath
Journal:  Dev Biol       Date:  2008-11-06       Impact factor: 3.582

5.  Mice deficient in stem cell antigen-1 (Sca1, Ly-6A/E) develop normal primary and memory CD4+ and CD8+ T-cell responses to virus infection.

Authors:  Jason K Whitmire; Boreth Eam; J Lindsay Whitton
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

6.  Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.

Authors:  Lori S Ahrenhoerster; Everett R Tate; Peter A Lakatos; Xuexia Wang; Michael D Laiosa
Journal:  Toxicol Appl Pharmacol       Date:  2014-04-04       Impact factor: 4.219

7.  Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive chemicals.

Authors:  Rachel Frawley; Kimber White; Ronnetta Brown; Deborah Musgrove; Nigel Walker; Dori Germolec
Journal:  Environ Health Perspect       Date:  2010-11-01       Impact factor: 9.031

8.  Contribution of a single host genetic locus to mouse adenovirus type 1 infection and encephalitis.

Authors:  Tien-Huei Hsu; Irene W Althaus; Oded Foreman; Katherine R Spindler
Journal:  MBio       Date:  2012-05-29       Impact factor: 7.867

9.  Altered proliferative response by T lymphocytes of Ly-6A (Sca-1) null mice.

Authors:  W L Stanford; S Haque; R Alexander; X Liu; A M Latour; H R Snodgrass; B H Koller; P M Flood
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

10.  Protection from anti-TCR/CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1/stem cell antigen-2.

Authors:  S Noda; A Kosugi; S Saitoh; S Narumiya; T Hamaoka
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.